1. Hyaluronic Acid-Functionalized Polydopamine Nanoparticles Augment Photothermal Therapy via Synergetic Tumor-Targeting and Heat Shock Protein Inhibition
    Lingyun Ruan et al, 2023, ACS Applied Nano Materials CrossRef
  2. Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells
    Harry Lee et al, 2018, Scientific Reports CrossRef
  3. Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis
    Jürgen Thanner et al, 2020, OncoImmunology CrossRef
  4. Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
    Sangkyu Park et al, 2019, Biomolecules & Therapeutics CrossRef
  5. The Heat Shock Protein Story—From Taking mTORC1,2 and Heat Shock Protein Inhibitors as Therapeutic Measures for Treating Cancers to Development of Cancer Vaccines
    Peter Chin Wan Fung et al, 2017, Journal of Cancer Therapy CrossRef
  6. Effect of geldanamycin on the expression of the matrix molecules and angiogenetic factors in a gastric cancer cell line
    T. Gürpınar et al, 2021, Biotechnic & Histochemistry CrossRef
  7. HSP90 Inhibitor Ganetespib (STA-9090) Inhibits Tumor Growth in c-Myc-Dependent Esophageal Squamous Cell Carcinoma


    Liuliu Guan et al, 2020, OncoTargets and Therapy CrossRef
  8. Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers
    Martin Gutierrez et al, 2021, Lung Cancer CrossRef
  9. HSP90 and Co-chaperones: Impact on Tumor Progression and Prospects for Molecular-Targeted Cancer Therapy
    Ameneh Jafari et al, 2020, Cancer Investigation CrossRef